Mass drug administration for malaria
CONCLUSIONS: In moderate- to high-transmission settings, no studies reported important effects on P falciparum parasitaemia prevalence within six months after MDA. In very low- to low-transmission settings, parasitaemia prevalence and incidence were reduced initially for up to three months for both P falciparum and P vivax; longer-term data did not demonstrate an effect after four months, but absolute risks in both intervention and control groups were low. No studies provided evidence of interruption of malaria transmission.PMID:34585740 | DOI:10.1002/14651858.CD008846.pub3
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Monica P Shah Jimee Hwang Leslie Choi Kim A Lindblade S Patrick Kachur Meghna Desai Source Type: research
More News: Burkina Faso Health | Cambodia Health | Conferences | Databases & Libraries | Endemics | Gambia Health | General Medicine | Kenya Health | Laos Health | Malaria | Myanmar Health | Nigeria Health | Parasitology | Study | Vietnam Health | Zambia Health